The focus of this application is on the molecular mechanisms of action of genetically controlled elements in autoimmunity. the overall objective of this program is to identify, study, and understand several of the key genetic parameters which underlie disease susceptibility and autoimmune activation. Project 1 investigates the molecular interactions which trigger cellular activation in immune-mediated events in autoimmunity. The specific objective is to identify and dissect the critical structural characteristics of T cell receptor molecules which can interact with HLA-DR elements implicated by prior genetic analyses as being involved in susceptibility to autoimmune disease. Project 2 evaluates the role of intra-cellular molecular interactions in autoimmunity, specifically, class II-peptide interactions and affinities during antigen presentation. Project 3 focuses one step back on the pathway of HLA contributions to autoimmunity, evaluating the role of promoter region polymorphisms relative to transcriptional activity associated with HLA-DR susceptibility genes. Project 4 will evaluate the VH repertoire and its relationship to germline encoded autoantibodies. Each of these projects is likely to define critical elements of the immune response pathway and lead to a better understanding of the molecular and genetic mechanisms of autoimmunity. This is a highly technical, detail-oriented proposal, emphasizing new ideas and new initiatives. We have specifically selected innovative, non- traditional approaches to important questions in autoimmunity, as we feel that this orientation is timely, building upon work by us and others over the past decade which has focused on identifying candidate susceptibility genes for autoimmunity. The innovative nature of these projects and their common emphasis on molecular mechanisms invite high degree of technical and conceptual synergy well suited for a program project.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI031241-01
Application #
3092121
Study Section
Special Emphasis Panel (SRC (85))
Project Start
1991-09-01
Project End
1995-07-31
Budget Start
1991-09-01
Budget End
1992-07-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Benaroya Research Institute at Virginia Mason
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98101
Wei, S; Charmley, P; Concannon, P (1997) Organization, polymorphism, and expression of the human T-cell receptor AV1 subfamily. Immunogenetics 45:405-12
Brawley, J V; Concannon, P (1996) Modulation of promiscuous T cell receptor recognition by mutagenesis of CDR2 residues. J Exp Med 183:2043-51
Pinchuk, G V; Nottenburg, C; Milner, E C (1995) Predominant V-region gene configurations in the human antibody response to Haemophilus influenzae capsule polysaccharide. Scand J Immunol 41:324-30
Kovats, S; Nepom, G T; Coleman, M et al. (1995) Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome. J Clin Invest 96:217-23
Milner, E C; Hufnagle, W O; Glas, A M et al. (1995) Polymorphism and utilization of human VH Genes. Ann N Y Acad Sci 764:50-61
Pinchuk, G V; Nottenburg, C; Milner, E C (1995) Patterns of V-region gene segment association in the human antibody response to Haemophilus influenzae type B capsular polysaccharide. Ann N Y Acad Sci 764:378-80
Glas, A M; Hufnagle, W O; Suzuki, I et al. (1995) Anomalous diversification of the antibody repertoire following bone marrow transplantation. Ann N Y Acad Sci 764:312-4
Suzuki, I; Pfister, L; Glas, A et al. (1995) Representation of rearranged VH gene segments in the human adult antibody repertoire. J Immunol 154:3902-11
Hufnagle, W O; Huang, S C; Suzuki, I et al. (1995) A complete preimmune human VH3 repertoire. Ann N Y Acad Sci 764:293-5
Kovats, S; Drover, S; Marshall, W H et al. (1994) Coordinate defects in human histocompatibility leukocyte antigen class II expression and antigen presentation in bare lymphocyte syndrome. J Exp Med 179:2017-22

Showing the most recent 10 out of 14 publications